Evidence map›Paper›PMID 38918691›Full record

ArticleBMC infectious diseases2024

Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022.

Antonio Antonelli, Maria Elena Ales, Greta Chiecca, Zeno Dalla Valle, Emanuele De Ponti, Danilo Cereda, Lucia Crottogini, Cristina Renzi, Carlo Signorelli, Matteo Moro

Abstract read
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Antonio AntonelliUniversità Vita Salute San Raffaele, Via Olgettina 58, Milan, 20132, Italy. antonelli.antonio@hsr.it.
Maria Elena AlesUniversità Vita Salute San Raffaele, Via Olgettina 58, Milan, 20132, Italy.
Greta ChieccaUniversità Vita Salute San Raffaele, Via Olgettina 58, Milan, 20132, Italy.
Zeno Dalla ValleUniversità Vita Salute San Raffaele, Via Olgettina 58, Milan, 20132, Italy.
Emanuele De PontiUniversità Vita Salute San Raffaele, Via Olgettina 58, Milan, 20132, Italy.
Danilo CeredaRegione Lombardia Direzione Generale Welfare, Milan, Italy.
Lucia CrottoginiRegione Lombardia Direzione Generale Welfare, Milan, Italy.
Cristina RenziUniversità Vita Salute San Raffaele, Via Olgettina 58, Milan, 20132, Italy.
Carlo SignorelliUniversità Vita Salute San Raffaele, Via Olgettina 58, Milan, 20132, Italy.
Matteo MoroIRCCS Ospedale San Raffaele, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare-Associated Infections (HAIs) are a global public health issue, representing a significant burden of disease that leads to prolonged hospital stays, inappropriate use of antimicrobial drugs, intricately linked to the development of resistant microorganisms, and higher costs for healthcare systems. The study aimed to measure the prevalence of HAIs, the use of antimicrobials, and assess healthcare- and patient-related risk factors, to help identify key intervention points for effectively reducing the burden of HAIs.

methodsA total of 28 acute care hospitals in the Lombardy region, Northern Italy, participated in the third European Point Prevalence Survey (PPS-3) coordinated by ECDC for the surveillance of HAIs in acute care hospitals (Protocol 6.0).

resultsHAIs were detected in 1,259 (10.1%, 95% CI 9.6-10.7%) out of 12,412 enrolled patients. 1,385 HAIs were reported (1.1 HAIs per patient on average). The most common types of HAIs were bloodstream infections (262 cases, 18.9%), urinary tract infections (237, 17.1%), SARS-CoV-2 infections (236, 17.0%), pneumonia and lower respiratory tract infections (231, 16.7%), and surgical site infections (152, 11.0%). Excluding SARS-CoV-2 infections, the overall prevalence of HAIs was 8.4% (95% CI 7.9-8.9%). HAIs were significantly more frequent in patients hospitalized in smaller hospitals and in intensive care units (ICUs), among males, advanced age, severe clinical condition and in patients using invasive medical devices. Overall, 5,225 patients (42.1%, 95% CI 41.3-43.0%) received systemic antimicrobial therapy. According to the WHO's AWaRe classification, the Access group accounted for 32.7% of total antibiotic consumption, while Watch and Reserve classes accounted for 57.0% and 5.9% respectively. From a microbiological perspective, investigations were conducted on only 64% of the HAIs, showing, however, a significant pattern of antibiotic resistance.

conclusionsThe PPS-3 in Lombardy, involving data collection on HAIs and antimicrobial use in acute care hospitals, highlights the crucial need for a structured framework serving both as a valuable benchmark for individual hospitals and as a foundation to effectively channel interventions to the most critical areas, prioritizing future regional health policies to reduce the burden of HAIs.

Indexed as

Cross InfectionHospitalsAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsAnti-Infective AgentsChildChild, PreschoolCOVID-19FemaleHumansInfantInfant, NewbornItalyAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial stewardshipAntimicrobial useHealthcare associated infectionInfection prevention and controlPoint prevalence surveySurveillance

Identifiers

PMID38918691
PMCPMC11197227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.